title: Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient study.
abstract: Integrated systems combining functional (single-photon emission computed tomography; SPECT) imaging with anatomic (computed tomography; CT) imaging have the potential to greatly improve the accuracy of dose estimation in radionuclide therapy. In this article, we present the methodology for highly patient-specific tumor dosimetry by utilizing such a system and apply it to a pilot study of 4 follicular lymphoma patients treated with I-131 tositumomab. SPECT quantification included three-dimensional ordered-subset expectation-maximization reconstruction and CT-defined tumor outlines at each time point. SPECT/CT images from multiple time points were coupled to a Monte Carlo algorithm to calculate a mean tumor dose that incorporated measured changes in tumor volume. The tumor shrinkage, defined as the difference between volumes drawn on the first and last CT scan (a typical time period of 15 days) was in the range 5%-49%. The therapy-delivered mean tumor-absorbed dose was in the range 146-334 cGy. For comparison, the therapy dose was also calculated by assuming a static volume from the initial CT and was found to underestimate this dose by up to 47%. The agreement between tracer-predicted and therapy-delivered tumor-absorbed dose was in the range 7%-21%. In summary, malignant lymphomas can have dramatic tumor regression within days of treatment, and advanced imaging methods allow for a highly patient-specific tumor-dosimetry calculation that accounts for this regression.
authors.affiliation: Division of Nuclear Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA. yuni@umich.edu
authors.forename: Yuni K
authors.initials: YK
authors.lastname: Dewaraja
authors.forename: Scott J
authors.initials: SJ
authors.lastname: Wilderman
authors.forename: Kenneth F
authors.initials: KF
authors.lastname: Koral
authors.forename: Mark S
authors.initials: MS
authors.lastname: Kaminski
authors.forename: Anca M
authors.initials: AM
authors.lastname: Avram
mesh_terms: D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008224:Lymphoma, Follicular / Q000000981:diagnostic imaging / Q000378:metabolism / Q000532:radiotherapy*; D010865:Pilot Projects; D016499:Radioimmunotherapy / Q000379:methods*; D011874:Radiometry / Q000379:methods; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D015899:Tomography, Emission-Computed, Single-Photon / Q000295:instrumentation / Q000379:methods; D014057:Tomography, X-Ray Computed / Q000379:methods
chemical_list: D000911:Antibodies, Monoclonal; D007457:Iodine Radioisotopes; C119496:tositumomab I-131
references.citation: Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):4003S-6S
references.pmid: 14506200
references.citation: J Nucl Med. 2003 Feb;44(2):260-8
references.pmid: 12571219
references.citation: N Engl J Med. 2005 Feb 3;352(5):441-9
references.pmid: 15689582
references.citation: Rofo. 2002 Dec;174(12):1570-6
references.pmid: 12471531
references.citation: J Nucl Med. 1996 Dec;37(12):1970-5
references.pmid: 8970516
references.citation: Cancer Biother Radiopharm. 2002 Feb;17(1):83-99
references.pmid: 11915176
references.citation: J Nucl Med. 1999 Aug;40(8):1317-26
references.pmid: 10450684
references.citation: Med Phys. 1993 Nov-Dec;20(6):1667-74
references.pmid: 8309439
references.citation: IEEE Trans Nucl Sci. 2007 Feb 17;54(1):146-151
references.pmid: 20305792
references.citation: Phys Med Biol. 2007 Feb 7;52(3):777-90
references.pmid: 17228120
references.citation: Phys Med Biol. 2006 Jul 7;51(13):R187-202
references.pmid: 16790903
references.citation: J Nucl Med. 2007 Jun;48(6):1008-16
references.pmid: 17504874
references.citation: J Clin Oncol. 1998 Oct;16(10):3246-56
references.pmid: 9779698
references.citation: J Nucl Med. 2003 Aug;44(8):1322-9
references.pmid: 12902424
references.citation: Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):458-69
references.pmid: 15821965
references.citation: IEEE Trans Nucl Sci. 2006;53(1):181
references.pmid: 20104252
references.citation: Med Phys. 1994 Jul;21(7):1157-62
references.pmid: 7968849
references.citation: J Nucl Med. 2005 May;46(5):840-9
references.pmid: 15872359
references.citation: J Nucl Med. 2010 Apr;51(4):654-9
references.pmid: 20237032
references.citation: Phys Med Biol. 2000 Aug;45(8):2263-91
references.pmid: 10958194
references.citation: Clin Cancer Res. 2004 Dec 1;10(23):7792-8
references.pmid: 15585610
references.citation: J Nucl Med. 2006 Sep;47(9):1406-12
references.pmid: 16954546
references.citation: Med Phys. 1998 Jan;25(1):85-91
references.pmid: 9472830
references.citation: J Clin Oncol. 1996 Jul;14(7):1974-81
references.pmid: 8683227
references.citation: J Nucl Med. 2003 Mar;44(3):457-64
references.pmid: 12621015